Susovan Jana, PhD
Dr. Susovan Jana obtained his BSc (2008) degree in Chemistry from RKMR College Narendrapur, University of Calcutta, WB, India and earned his MSc (2010) in Chemistry at Indian Institute of Technology, Kharagpur (Kharagpur, WB, India). Following an additional year of fellowship studies at IIT, he then moved to Florida Atlantic University (Boca Raton, FL) to pursue doctoral studies under the direction of Prof. Salvatore Lepore and graduated with PhD degree in Aug. 2018. During his doctoral research, he designed and developed a new approach to the rapid fluorination of organosilicon compounds for their application in PET utilizing bifunctional crown ether nucleophilic catalysts (CENCs). Dr. Jana also designed novel reaction methodologies involving γ-silylallenyl esters and discovered an exciting diversification reaction of γ-silylallenyl esters leading to the selective formation of highly functionalized all-carbon quaternary stereogenic centers and dicarbinols as small molecule building blocks for bioactive natural products. In 2016, Dr. Jana was selected for a year-long internship at GlaxoSmithKline (GSK, Collegeville, PA) in their Respiratory Medicinal Chemistry Division, where he designed and synthesized analogs to inhibit Keap1-NRF2 protein-protein interaction for the amelioration of oxidative stress.
In Dec. 2018, Dr. Jana joined the PET Radiopharmaceutical Sciences Section (PRSS, MIB) at the National Institute of Mental Health, NIH as a postdoctoral fellow. His ongoing research includes design and development of carbon-11 and fluorine-18 candidate PET radiotracers to quantify neuroinflammation via brain imaging and the development of new radiolabeling methods involving [11C]/[18F]fluoroform for the labeling of small molecules.